Opportunity Information: Apply for RFA CK 11 005
Apply for RFA CK 11 005
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.942 Research, Prevention, and Education Programs on Lyme Disease in the United States.
- This funding opportunity was created on Feb 9, 2011 and posted on Dec 21, 2010.
- Applicants must submit their applications by Mar 14, 2011 On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM Eastern Time. Note.HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease" (Funding Opportunity Number RFA CK 11 005) was issued by the Centers for Disease Control and Prevention (CDC) as a discretionary funding opportunity using a cooperative agreement mechanism. Its central aim was to push forward practical and effective tick control technologies that can lower the entomological risk of Lyme disease, meaning it focused on reducing tick populations and/or the presence of infected ticks in ways that translate into reduced risk for people. The emphasis on both individual and integrated tick management suggests the CDC was interested not only in single, stand-alone interventions, but also in combinations of approaches that work together as a coordinated strategy, which is often what "integrated" implies in vector control and public health pest management contexts.
This opportunity fell under the health activity category and was associated with CFDA 93.942, which covers research, prevention, and education programs on Lyme disease in the United States. The funding instrument being a cooperative agreement is significant because it typically indicates a more active partnership with the CDC compared to a standard grant. In cooperative agreements, the agency usually anticipates substantial involvement in the funded work, which can include collaboration on study design elements, coordination across sites, technical guidance, or involvement in dissemination and evaluation planning. Even though the short description here is brief, the structure strongly signals that funded projects were expected to generate actionable evidence about how well tick control tools or ITM packages reduce tick-related risk factors that matter for Lyme disease prevention.
In terms of funding size and scope, the CDC expected to make two awards, with an award ceiling of $300,000. The award floor was listed as $0, which generally functions as an administrative placeholder rather than an expectation of zero-dollar awards; practically, it means applicants had flexibility in proposing budgets up to the maximum, depending on project design and scale. There was no cost sharing or matching requirement, so applicants were not required to contribute non-federal funds as a condition of eligibility or competitiveness, which can make participation more feasible for smaller organizations, local entities, or research teams without substantial discretionary resources.
Eligibility was described as unrestricted, meaning it was broadly open to many entity types, subject to any additional clarifications that would have appeared in the full announcement. In practice, language like this typically allows applications from universities, non-profits, for-profits, state and local governments, tribal organizations, and other qualified entities, assuming they meet standard federal grant requirements and any program-specific conditions. Because the project topic is tick management and Lyme prevention, the most natural applicants would include academic research groups, public health agencies, mosquito and vector control districts (where relevant to tick work), and organizations with field trial capacity in Lyme-endemic areas.
The timeline provided shows the opportunity was posted on December 21, 2010, with a listed creation date of February 9, 2011. The application deadline (both original and current closing date) was March 14, 2011, with an explicit submission requirement: applications had to be submitted electronically through Grants.gov and then successfully validated through eRA Commons by 5:00 PM Eastern Time on the due date. A particularly important detail is that the CDC noted there was no post-deadline error correction window. That means applicants needed to ensure their submission was error-free and fully accepted by the relevant federal systems before the deadline; if the systems flagged an error after 5:00 PM ET, the applicant would not have an additional grace period to fix and resubmit. The archive date of April 13, 2011 indicates when the opportunity was formally closed out for public posting purposes.
Overall, the opportunity was a targeted CDC investment intended to strengthen the evidence base and practical capabilities for tick control as a Lyme disease prevention strategy. By focusing on the ability of individual tools and integrated management approaches to reduce entomological risk, it implicitly prioritized measurable, field-relevant outcomes connected to ticks and pathogen risk rather than purely laboratory or theoretical work. For anyone who needed more information at the time, the listing directed inquiries to the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), with a provided phone number (770-488-2700) and a general email contact (not fully shown in the excerpt).
FAQs: Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease (RFA CK 11 005)
What is the title of this grant opportunity?
The opportunity is titled "Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA CK 11 005.
Which federal agency offered this opportunity?
This opportunity was issued by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism was used?
The CDC offered this as a cooperative agreement under its discretionary funding opportunities.
What does it mean that this is a cooperative agreement?
A cooperative agreement typically indicates that the CDC expected to have substantial involvement in the funded work compared to a standard grant. That involvement can include collaboration on study design elements, coordination across sites, technical guidance, and participation in dissemination and evaluation planning.
What is the main purpose of the opportunity?
The central aim was to advance practical and effective tick control technologies that can reduce the entomological risk of Lyme disease by reducing tick populations and/or reducing the presence of infected ticks in ways that translate into reduced risk for people.
What does "entomological risk of Lyme disease" mean in this context?
In this context, it refers to tick-related risk factors for Lyme disease, such as tick abundance and the presence of infected ticks, with an emphasis on outcomes that matter for prevention.
What kinds of approaches were included: individual tools, integrated strategies, or both?
Both. The CDC emphasized individual tick management technologies as well as integrated tick management (ITM) approaches, meaning coordinated combinations of approaches that work together as a strategy.
What does "integrated tick management (ITM)" imply here?
"Integrated" generally implies combining multiple tick control interventions into a coordinated management strategy, which is a common concept in vector control and public health pest management.
What activity category did this opportunity fall under?
This opportunity fell under the health activity category.
What CFDA number was associated with this opportunity?
The opportunity was associated with CFDA 93.942.
What does CFDA 93.942 cover?
CFDA 93.942 covers research, prevention, and education programs on Lyme disease in the United States.
How many awards did the CDC expect to make?
The CDC expected to make two awards.
What was the maximum funding amount per award?
The award ceiling was $300,000.
What was the minimum funding amount (award floor)?
The award floor was listed as $0, which is typically an administrative placeholder rather than an expectation of zero-dollar awards, and generally indicates flexibility in proposing budgets up to the ceiling based on project design and scale.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement.
Who was eligible to apply?
Eligibility was described as unrestricted, meaning it was broadly open to many entity types, subject to any additional details that would have appeared in the full announcement.
What types of applicants would be a natural fit for this topic?
Likely applicants would include universities, public health agencies, and organizations with field trial capacity in Lyme-endemic areas. The description also suggests potential fit for entities like mosquito and vector control districts (where relevant to tick work) and other qualified organizations capable of conducting tick management evaluations.
When was the opportunity posted?
The opportunity was posted on December 21, 2010.
What creation date was listed for the opportunity?
The listing shows a creation date of February 9, 2011.
What was the application deadline?
The application deadline was March 14, 2011.
How did applicants have to submit their applications?
Applications had to be submitted electronically through Grants.gov and then successfully validated through eRA Commons.
What time was the submission due?
Applications had to be submitted and validated by 5:00 PM Eastern Time on the due date.
Was there a post-deadline error correction window?
No. The CDC explicitly noted there was no post-deadline error correction window, meaning submissions needed to be error-free and fully accepted by the federal systems before the deadline.
What does "no error correction window" mean for applicants?
It means that if an application was submitted but later flagged with errors after 5:00 PM Eastern Time, the applicant would not have an additional grace period to fix issues and resubmit.
When was the opportunity archived?
The archive date was April 13, 2011.
What kinds of outcomes were implicitly prioritized by the CDC in this opportunity?
The description suggests a priority on measurable, field-relevant outcomes connected to ticks and pathogen risk, rather than purely laboratory or theoretical work, with an emphasis on evidence that can inform Lyme disease prevention.
Who was listed as the contact for more information?
Inquiries were directed to the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
What phone number was provided for the listed contact?
The phone number provided was 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Fisheries Science Exchange
Previous opportunity: National Park Service Wayside Exhibit Evaluation, Consultation, and Expanded Audience Opportunities
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 11 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 11 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Combining Subjective and Objective Methods for Quantifying Contact Rates and Mixing Pattern in School Aged Children Apply for RFA CK 11 006 Funding Number: RFA CK 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) Apply for PAR 11 083 Funding Number: PAR 11 083 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R01) Apply for PAR 11 082 Funding Number: PAR 11 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Spina Bifida Registry Longitudinal Data Collection and Evaluation (U01) Apply for RFA DD 11 005 Funding Number: RFA DD 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| NIAID Science Education Awards (R25) Apply for PAR 11 086 Funding Number: PAR 11 086 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Georgia Tuberculosis Prevention Project Apply for RFA 114 11 000001 Funding Number: RFA 114 11 000001 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $4,450,000 |
| Studies at the Animal Human Interface of Influenza and Other Zoonotic Diseases in Vietnam Apply for RFA IP 11 005 Funding Number: RFA IP 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Influenza and Other Respiratory Diseases in Southern Hemisphere Apply for RFA IP 11 014 Funding Number: RFA IP 11 014 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Campus Suicide Prevention Grants Apply for SM 11 002 Funding Number: SM 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $102,000 |
| Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention Apply for SM 11 001 Funding Number: SM 11 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $480,000 |
| Cooperative Agreement with the Catholic Relief Services (CRS) Apply for CDC RFA GH11 11104 Funding Number: CDC RFA GH11 11104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India Apply for RFA IP 11 012 Funding Number: RFA IP 11 012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Influenza Vaccine Efficacy in Tropical and Developing Countries Apply for RFA IP 11 013 Funding Number: RFA IP 11 013 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantee Sites Apply for HRSA 11 101 Funding Number: HRSA 11 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Sustainable Responses for Improving the Lives of Vulnerable Children and their Households Apply for RFA 617 11 000001 Funding Number: RFA 617 11 000001 Agency: Uganda USAID Kampala Category: Health Funding Amount: $29,500,000 |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Apply for PA 11 087 Funding Number: PA 11 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Apply for PA 11 088 Funding Number: PA 11 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Apply for PA 11 089 Funding Number: PA 11 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NHLBI Investigator Initiated Resource Related Research Projects (R24) Apply for PAR 11 090 Funding Number: PAR 11 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Access to Emergency Devices Apply for HRSA 11 088 Funding Number: HRSA 11 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 11 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.